Neural Precursor Cell Expansion in Bioreactors
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for culturing neuronal precursor cells (NPCs) are limited by the lack of scalable and controlled processes, making it difficult to produce sufficient cells for clinical applications, particularly for neurodegenerative disorders like Parkinson's and Huntington's disease, where fetal tissue availability is a significant concern.
Innovation Solution
A serum-free culture medium comprising specific nutrients, growth factors, and hormones is used in large-scale bioreactors to cultivate NPCs, allowing for controlled expansion and differentiation, with conditions optimized for pH, oxygenation, and agitation to maintain cell viability and aggregate size.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If fetal tissue is used for cell replacement therapy, then clinical benefits are achieved, but tissue availability is limited and ethical controversies arise
Solution Approach 1:
The patent creates copies of neural precursor cells through in vitro expansion of fetal-derived cells. A small initial sample of fetal neural precursor cells is cultured and multiplied using specific growth factors (bFGF, EGF, LIF) and optimized culture conditions, producing large quantities of cells that can be used for multiple transplantations, thereby eliminating the need to procure tissue from multiple fetuses for each patient.
Solution Approach 2:
The patent performs preliminary expansion and characterization of neural precursor cells in controlled laboratory conditions before clinical transplantation. Cells are pre-cultured, differentiated, and validated for safety and efficacy, allowing thorough preparation and quality control before actual patient treatment, which reduces the need for repeated fetal tissue procurement.
2Reliability
If small-scale culture methods are used for NPCs, then cell viability is maintained, but large-scale production for clinical use is not achieved
Solution Approach 1:
The patent systematically optimizes culture parameters including growth factor concentrations (bFGF 10-50 ng/mL, EGF 10-50 ng/mL, LIF 10-50 U/mL), oxygen tension (5-20% O2), pH (7.2-7.4), and temperature (37°C) to maintain high cell viability during scale-up. These parameter optimizations enable transition from small-scale to large-scale bioreactor culture while preserving cell health and function.
Solution Approach 2:
The patent divides the large-scale culture process into manageable stages: initial cell expansion in small flasks, intermediate expansion in larger bioreactors, and final production-scale expansion. This segmented approach allows progressive scale-up while maintaining control over culture conditions and cell quality at each stage.
Data Source
AI summary
The present invention provides methods and compositions for the propagation and expansion of neural precursor cells (NPCs). NPCs may be used in the clinical implementation of stem cell therapy to treat disorders such as Parkinson's disease, Huntington's disease, neuropathic pain and other diseases of the central nervous system. The large-scale production of NPCs in bioreactors allows for the generation of clinical quantities of these cells.